Search

everythinglearnresearchcommunity

for

Search:↓

Autoimmune-related phenomena do not affect the progression or characteristics of lichen sclerosus in women.

People with lupus and rheumatoid arthritis have thinner hair than healthy people.

A woman with Rhupus and Rowell syndrome was treated successfully with medication adjustments.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.

Syphilis should be considered if PLEVA-like symptoms don't improve with treatment.

Early detection of Graham-Little-Piccardi-Lasseur syndrome is key for better management.

Many patients with autoimmune blistering skin disorders change their diets, avoiding foods like alcohol, citrus, and spices, and some find vegetables and dairy helpful.

Platelet-rich plasma (PRP) is an effective treatment for lichen planopilaris.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

Triple therapy with clobetasol, hydroxychloroquine, and N-acetylcysteine is recommended for better outcomes in treating lichen planopilaris.

Dental procedures and immunosuppressants can lead to heart infections in lupus patients.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Early scar classification in lupus can improve treatment and patient outcomes.

Women are more likely to have Lichen planopilaris, and treatments with cyclosporine and methotrexate are most effective but less safe than mycophenolate mofetil.

Cocaine use can cause a blistering skin disease.

A machine learning model can predict scarring in lichen planopilaris using factors like vitamin D levels and diagnostic delay.

PRP and ADSC therapies show promise in improving symptoms of genital lichen sclerosus with minimal side effects.

Lichen planus pigmentosus and fibrosing frontal alopecia in Colombia are likely different stages of the same disease.

Methotrexate and azathioprine are equally effective and well-tolerated for treating lichen planopilaris.

Lichen planopilaris may be linked to autoimmune thyroiditis.

Effective treatments for discoid lupus erythematosus are needed, as current options are unsatisfactory and off-label.

Mitochondrial dysfunction may contribute to chronic inflammation and immune system issues in Lichen planopilaris.

Cord blood platelet-rich plasma may safely improve vulvar lichen sclerosus symptoms.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Thalidomide significantly improved hair regrowth in a woman with lichen planopilaris.

SLE in Iraqi patients often involves hair loss and photosensitivity, with common treatments being corticosteroids and immunosuppressants.

Certain drugs can cause skin lupus, but stopping the drug usually helps. Vaccines work against smallpox, genital herpes, and a type of human papillomavirus. More frequent light therapy clears psoriasis faster. Certain treatments work for psoriasis and dermatitis. A specific cream effectively treats a type of skin cancer. Low iron levels aren't directly linked to chronic hair loss.

Autoinflammatory skin diseases are complex, increasingly common, and significantly affect quality of life.

New tools were created to help lupus patients report their symptoms and impacts more accurately.

Lichen planopilaris patients are more likely to have hypothyroidism.